Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome.

Szilágyi A, Kiss N, Bereczki C, Tálosi G, Rácz K, Túri S, Györke Z, Simon E, Horváth E, Kelen K, Reusz GS, Szabó AJ, Tulassay T, Prohászka Z.

Nephrol Dial Transplant. 2013 Sep;28(9):2237-45. doi: 10.1093/ndt/gft198. Epub 2013 Jun 19.

PMID:
23787556
2.

[Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].

Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.

Rev Med Interne. 2011 Apr;32(4):232-40. doi: 10.1016/j.revmed.2009.09.039. Epub 2011 Mar 3. French.

3.

Atypical hemolytic uremic syndrome.

Loirat C, Frémeaux-Bacchi V.

Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60. Review.

4.

Investigating the role of pneumococcal neuraminidase A activity in isolates from pneumococcal haemolytic uraemic syndrome.

Smith A, Johnston C, Inverarity D, Slack M, Paterson GK, Diggle M, Mitchell T.

J Med Microbiol. 2013 Nov;62(Pt 11):1735-42. doi: 10.1099/jmm.0.063479-0. Epub 2013 Aug 7. Erratum in: J Med Microbiol. 2014 Apr;63(Pt 4):625. Paterson, Gavin K [added].

PMID:
23924664
5.

Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature.

Manenti L, Gnappi E, Vaglio A, Allegri L, Noris M, Bresin E, Pilato FP, Valoti E, Pasquali S, Buzio C.

Nephrol Dial Transplant. 2013 Sep;28(9):2246-59. doi: 10.1093/ndt/gft220. Epub 2013 Jun 19. Review.

PMID:
23787552
6.

Does dysregulated complement activation contribute to haemolytic uraemic syndrome secondary to Streptococcus pneumoniae?

Gilbert RD, Nagra A, Haq MR.

Med Hypotheses. 2013 Sep;81(3):400-3. doi: 10.1016/j.mehy.2013.05.030. Epub 2013 Jun 17.

PMID:
23786906
7.

First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis.

Szarvas N, Szilágyi Á, Tasic V, Nushi-Stavileci V, Sofijanova A, Gucev Z, Szabó M, Szabó A, Szeifert L, Reusz G, Rusai K, Arbeiter K, Müller T, Prohászka Z.

Ital J Pediatr. 2014 Dec 11;40:101. doi: 10.1186/s13052-014-0101-7.

8.

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1844-59. doi: 10.2215/CJN.02210310. Epub 2010 Jul 1.

9.

Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).

Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L.

Nephrol Dial Transplant. 2010 Jul;25(7):2195-202. doi: 10.1093/ndt/gfq010. Epub 2010 Jan 26.

PMID:
20106822
10.

Hemolytic uremic syndrome.

Mele C, Remuzzi G, Noris M.

Semin Immunopathol. 2014 Jul;36(4):399-420. doi: 10.1007/s00281-014-0416-x. Epub 2014 Feb 14. Review.

PMID:
24526222
11.

Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.

Dragon-Durey MA, Frémeaux-Bacchi V.

Springer Semin Immunopathol. 2005 Nov;27(3):359-74. Epub 2005 Nov 11. Review.

PMID:
16189652
12.

Familial haemolytic uraemic syndrome and an MCP mutation.

Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G; International Registry of Recurrent and Familial HUS/TTP..

Lancet. 2003 Nov 8;362(9395):1542-7.

PMID:
14615110
13.

Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M; European Working Party on Complement Genetics in Renal Diseases..

J Am Soc Nephrol. 2013 Feb;24(3):475-86. doi: 10.1681/ASN.2012090884. Epub 2013 Feb 21.

14.

Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange.

Reid VL, Mullan A, Erwig LP.

BMJ Case Rep. 2013 Sep 4;2013. pii: bcr2013200980. doi: 10.1136/bcr-2013-200980.

15.
16.

The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.

Kavanagh D, Burgess R, Spitzer D, Richards A, Diaz-Torres ML, Goodship JA, Hourcade DE, Atkinson JP, Goodship TH.

Mol Immunol. 2007 May;44(12):3162-7. Epub 2007 Mar 21.

PMID:
17368771
17.

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.

Fremeaux-Bacchi V, Kemp EJ, Goodship JA, Dragon-Durey MA, Strain L, Loirat C, Deng HW, Goodship TH.

J Med Genet. 2005 Nov;42(11):852-6. Epub 2005 Mar 22.

18.

Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children.

Janapatla RP, Hsu MH, Hsieh YC, Lee HY, Lin TY, Chiu CH.

Clin Microbiol Infect. 2013 May;19(5):480-6. doi: 10.1111/j.1469-0691.2012.03894.x. Epub 2012 May 16.

19.

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.

Westra D, Volokhina EB, van der Molen RG, van der Velden TJ, Jeronimus-Klaasen A, Goertz J, Gracchi V, Dorresteijn EM, Bouts AH, Keijzer-Veen MG, van Wijk JA, Bakker JA, Roos A, van den Heuvel LP, van de Kar NC.

Pediatr Nephrol. 2017 Feb;32(2):297-309. doi: 10.1007/s00467-016-3496-0. Epub 2016 Oct 7.

20.

Atypical haemolytic uraemic syndrome.

Kavanagh D, Goodship TH, Richards A.

Br Med Bull. 2006;77-78:5-22. Epub 2006 Sep 11. Review.

PMID:
16968692

Supplemental Content

Support Center